Filing Details

Accession Number:
0001415889-22-011810
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-29 07:00:11
Reporting Period:
2022-11-28
Accepted Time:
2022-11-29 07:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719406 Nrx Pharmaceuticals Inc. NRXP Pharmaceutical Preparations (2834) 822844431
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1864871 John Patrick Flynn C/O Nrx Pharmaceuticals, Inc.
1201 North Market Street, Suite 111
Wilmington DE 19801
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-28 2,500 $1.25 37,709 No 4 P Indirect By Trust
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-28 2,500 $1.25 40,209 No 4 P Indirect By Trust
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-28 2,500 $1.25 37,709 No 4 P Indirect By Trust
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-28 2,500 $1.24 40,209 No 4 P Indirect By Trust
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-28 1,750 $1.25 1,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Indirect By Trust
No 4 P Direct
Footnotes
  1. Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
  2. Held by the Whitney Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
  3. Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.
  4. Held by the Lindsay Pritchard Nash Flynn 2010 Trust of which the Reporting Person is trustee.